Regulatory T cells in type 1 autoimmune pancreatitis.
Regulatory T cells in type 1 autoimmune pancreatitis.
复制标题
DOI:
10.1155/2012/795026
复制
发表时间:
2012
影响因子:
2.3
通讯作者:
Okazaki K
中科院分区:
文献类型:
--
作者:
Uchida K;Kusuda T;Koyabu M;Miyoshi H;Fukata N;Sumimoto K;Fukui Y;Sakaguchi Y;Ikeura T;Shimatani M;Fukui T;Matsushita M;Takaoka M;Nishio A;Okazaki K
Autoimmune pancreatitis (AIP) is a newly recognized pancreatic disorder. Recently, International Consensus Diagnostic Criteria for AIP (ICDC) was published. In this ICDC, AIP was classified into Type 1 and Type 2. Patients with Type 1 AIP have several immunologic and histologic abnormalities specific to the disease, including increased levels of serum IgG4 and storiform fibrosis with infiltration of lymphocytes and IgG4-positive plasmacytes in the involved organs. Among the involved organs showing extrapancreatic lesions, the bile duct is the most common, exhibiting sclerosing cholangitis (IgG4-SC). However, the role of IgG4 is unclear. Recently, it has been reported that regulatory T cells (Tregs) are involved in both the development of various autoimmune diseases and the shift of B cells toward IgG4, producing plasmacytes. Our study showed that Tregs were increased in the pancreas with Type 1 AIP and IgG4-SC compared with control. In the patients with Type 1 AIP and IgG4-SC, the numbers of infiltrated Tregs were significantly positively correlated with IgG4-positive plasma cells. In Type 1 AIP, inducible costimulatory molecule (ICOS)+ and IL-10+ Tregs significantly increased compared with control groups. Our data suggest that increased quantities of ICOS+ Tregs may influence IgG4 production via IL-10 in Type 1 AIP.